Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Potential use of the PARP inhibitor rucaparib to enhance cervical cancer treatment.

Lookup NU author(s): Dr Santu SahaORCiD, Rachel Howarth, Dr Isabel PappworthORCiD, Professor Kevin MarchbankORCiD, Professor Nicola CurtinORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Publication metadata

Author(s): Saha S, Howarth R, Pappworth I, Marchbank K, Curtin N

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Year of Conference: 2020

Pages: S37-S37

Online publication date: 26/10/2020

Acceptance date: 26/10/2020

ISSN: 0959-8049

Publisher: Elsevier Ltd

URL: https://doi.org/10.1016/S0959-8049(20)31169-2

DOI: 10.1016/S0959-8049(20)31169-2

Series Title: European Journal of Cancer


Share